A.I. software that gives a voice and intelligence to products.
Post-money valuation โ
$10.1M
As of Apr 2024 ยท from SAPIENTX Preferred Stock 4 ยท pre-money + amount raised, not a traded price
Total raised
$2,870,568
Across 4 rounds since 2018
Latest share price
$0.65
SAPIENTX Preferred Stock 4 offering price
Financials
FY2016โFY2022 ยท from SEC filings ยท hover any figure for its source
$1K
โ$98K
2016
$53K
โ$92K
2017
$41K
โ$255K
2018
$530
โ$444K
2019
$0
โ$410K
2020
$39K
$568K
2021
$0
โ$996K
2022
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$1,000
$53,490
$41,010
$530
$0
$38,998
$0
Cost of goods sold
$0
$0
$0
$0
$0
$0
$0
Gross margin
100%
100%
100%
100%
โ
100%
โ
Net income
-$98,417
-$92,401
-$254,785
-$443,948
-$409,622
$567,670
-$995,887
Taxes paid
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$4,163
$17
$227,917
$8,577
$229,200
$5,445
$875,580
Accounts receivable
$0
$22,740
$0
$0
$0
$28,998
$0
Total assets
$185,969
$132,230
$265,057
$14,995
$229,655
$84,336
$1,058,220
Short-term debt
$0
$93,387
$117,439
$42,263
$176,819
$297,198
$210,167
Long-term debt
$56,833
$0
$0
$155,025
$0
$0
$0
Total liabilities
$56,833
$93,387
$117,439
$197,288
$176,819
$297,198
$210,167
Other
Headcount
โ
3
3
3
3
3
1
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.